Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells

The pro-homeostatic lipid mediators elovanoids (ELVs) attenuate cell binding and entrance of the SARS-CoV-2 receptor-binding domain (RBD) as well as of the SARS-CoV-2 virus in human primary alveoli cells in culture. We uncovered that very-long-chain polyunsaturated fatty acid precursors (VLC-PUFA, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Calandria, Jorgelina M., Bhattacharjee, Surjyadipta, Maness, Nicholas J., Kautzmann, Marie-Audrey I., Asatryan, Aram, Gordon, William C., Do, Khanh V., Jun, Bokkyoo, Mukherjee, Pranab K., Petasis, Nicos A., Bazan, Nicolas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192580/
https://www.ncbi.nlm.nih.gov/pubmed/34112906
http://dx.doi.org/10.1038/s41598-021-91794-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192580/
https://www.ncbi.nlm.nih.gov/pubmed/34112906
http://dx.doi.org/10.1038/s41598-021-91794-z

Ejemplares similares